论文信息 - Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA - 字舞流文

Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA

G. Lippi | Yang Luo | Bing-he Xu | A. Orlandi | G. Franceschini | P. Yuan | G. Marta | Shanbo Cao | M. Osman | Y. Naito | F. Ma | A. Zhu | Jiayu Wang | Pin Zhang | Qing Li | N. Hu | Xue Wang | J. Yue | Wen-miao Wang | Mingzhou Li